Medicine and Dentistry
Diabetes Mellitus
100%
Exenatide
100%
Combination Therapy
60%
Diabetes
40%
Caloric Intake
40%
Body Weight
40%
Insulin Sensitivity
40%
Maturity Onset Diabetes of the Young
20%
Beta Cell
20%
Glucagon Like Peptide 1
20%
Streptozocin
20%
Glucagon-Like Peptide-1 Agonist
20%
Disease
20%
Insulin Release
20%
Glucose Tolerance
20%
Glutathione Reductase
20%
Low Drug Dose
20%
Hemoglobin A1c
20%
Triacylglycerol
20%
Glycemic Control
20%
Nutrition Supplement
20%
Alanine Aminotransferase
20%
Corticosterone
20%
Interleukin 6
20%
11beta Hydroxysteroid Dehydrogenase
20%
Treatment Group
20%
Pharmacology, Toxicology and Pharmaceutical Science
Exendin 4
100%
Diabetes Mellitus
100%
Combination Therapy
60%
Mouse Model
20%
Glucagon-Like Peptide-1
20%
Streptozotocin
20%
Glucagon Like Peptide 1 Receptor Agonist
20%
Nutrition Supplement
20%
Alanine Aminotransferase
20%
Hemoglobin A1c
20%
Interleukin 6
20%
Triacylglycerol
20%
Glutathione Reductase
20%
Corticosterone
20%
Non Insulin Dependent Diabetes Mellitus
20%
11beta Hydroxysteroid Dehydrogenase
20%
Treatment Group
20%